Quoin Pharmaceuticals QNRX Stock
Quoin Pharmaceuticals Price Chart
Quoin Pharmaceuticals QNRX Financial and Trading Overview
| Quoin Pharmaceuticals stock price | 4.41 USD |
| Previous Close | 5.06 USD |
| Open | 4.94 USD |
| Bid | 4.92 USD x 200 |
| Ask | 4.82 USD x 200 |
| Day's Range | 4.69 - 5 USD |
| 52 Week Range | 4.55 - 41.8 USD |
| Volume | 31K USD |
| Avg. Volume | 96.3K USD |
| Market Cap | 9.58M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.07 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.75 USD |
QNRX Valuation Measures
| Enterprise Value | 289.25M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.2231026 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.5447808 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -16.657 |
Trading Information
Quoin Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -46.82% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 41.8 USD |
| 52 Week Low | 4.55 USD |
| 50-Day Moving Average | 6.11 USD |
| 200-Day Moving Average | 9.58 USD |
QNRX Share Statistics
| Avg. Volume (3 month) | 96.3K USD |
| Avg. Daily Volume (10-Days) | 39.97K USD |
| Shares Outstanding | 2.01M |
| Float | 50.45M |
| Short Ratio | 3.61 |
| % Held by Insiders | 2.63% |
| % Held by Institutions | 50.88% |
| Shares Short | 79.88K |
| Short % of Float | 3.98% |
| Short % of Shares Outstanding | 3.98% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -76.20% |
| Return on Equity (ttm) | -231.17% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -17364748 USD |
| Net Income Avi to Common (ttm) | -16990212 USD |
| Diluted EPS (ttm) | -10.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.04M USD |
| Total Cash Per Share (mrq) | 0.22 USD |
| Total Debt (mrq) | 2.17M USD |
| Total Debt/Equity (mrq) | 24.78 USD |
| Current Ratio (mrq) | 2.868 |
| Book Value Per Share (mrq) | 8.756 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15815738 USD |
| Levered Free Cash Flow (ttm) | -9524974 USD |
Profile of Quoin Pharmaceuticals
| Country | United States |
| State | VA |
| City | Ashburn |
| Address | 42127 Pleasant Forest Court |
| ZIP | 20148-7349 |
| Phone | 703 980 4182 |
| Website | https://quoinpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Q&A For Quoin Pharmaceuticals Stock
What is a current QNRX stock price?
Quoin Pharmaceuticals QNRX stock price today per share is 4.41 USD.
How to purchase Quoin Pharmaceuticals stock?
You can buy QNRX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Quoin Pharmaceuticals?
The stock symbol or ticker of Quoin Pharmaceuticals is QNRX.
Which industry does the Quoin Pharmaceuticals company belong to?
The Quoin Pharmaceuticals industry is Biotechnology.
How many shares does Quoin Pharmaceuticals have in circulation?
The max supply of Quoin Pharmaceuticals shares is 2.01M.
What is Quoin Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Quoin Pharmaceuticals PE Ratio is now.
What was Quoin Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Quoin Pharmaceuticals EPS is -10.07 USD over the trailing 12 months.
Which sector does the Quoin Pharmaceuticals company belong to?
The Quoin Pharmaceuticals sector is Healthcare.
Quoin Pharmaceuticals QNRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26897.04 USD — |
+0.16
|
6.3B USD — | 26554.24 USD — | 26923.7 USD — | — - | 6.3B USD — |
| US Tech Health Care IXHC | 1159.55 USD — |
+2.3
|
— — | 1146.48 USD — | 1165.81 USD — | — - | — — |
- {{ link.label }} {{link}}